MKI67 and laryngotracheoesophageal cleft: The aim of this study was to assess the value of Ki‐67 PI in predicting LC and disease‐specific survival (DSS) after primary RT in a well‐defined consecutive series of patients with early‐stage (T1‐T2) LSCC.